Letters To The Editor

In reply: Prostate cancer prevention

Author and Disclosure Information


In Reply: Although the two drugs were not compared head to head, the data from randomized trials suggest that they have similar effects on the amelioration of lower urinary tract symptoms due to benign prostatic hypertrophy. The full results of the REDUCE trial are not yet available and until they are published it is not possible to comment any further on whether one or the other is the better choice for prevention of prostate cancer.

Next Article:

What’s new in prostate cancer screening and prevention?

Related Articles